http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2716142-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9008466a40998f8be8e54cd3aceb10a2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
filingDate 2013-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eaefdf6e34f2345569e67e2408ccd60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a99afd480d6a4e8e2e8c7031e949fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50755a6e51c098904ecfd7c7aa5c278f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d1b11d42f8871cc20416d6ecb12eeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b312b3e3cf21e0d312734c7512e96cd0
publicationDate 2019-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2716142-T3
titleOfInvention 1-Phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
abstract A compound of the general Formula (I) ** Formula ** wherein: R1 and R2 are the same or different and are independently selected from the group consisting of hydrogen, methyl, ethyl, difluoromethyl, cyclopropylmethyl or cyclopropyl; R3 are the same two chlorine atoms in position 3 and 5 of the pyridyl ring; Z is a group (CH2) m where m = 0; A is a phenyl ring, which is optionally substituted with one or more R4 substituents, which may be the same or different and are independently selected from the group consisting of: (C1-C2) linear or branched alkyl optionally substituted by one or more ( C3-C7) heterocycloalkyl and preferably 4-morpholinyl; trifluoromethyl; methylthio; halogen selected from fluoro or chloro; and OR7 wherein R7 is selected from the group consisting of -H; - (C1-C4) alkyl optionally substituted by a radical selected from OH, cyclopropyl, 4-morpholinyl, 1- or 4- piperidinyl, 4-pyridinyl and phenyl; - trifluoromethyl or difluoromethyl; and W is the group -NR9SO2R10 wherein R9 is selected from the group consisting of (C1-C4) alkyl optionally substituted by 4-morpholinyl, 1-piperidinyl, 1-pyrrolidinyl, piperazinyl, 1,2-thiazolidin-3-yl, piperazin-1-ylcarbonyl wherein any of said rings may be optionally substituted with one or more methyl, ethyl or OH; and R11R12N- (C1-C3) alkylene wherein R11 and R12 are independently H or methyl optionally substituted with an OH group; and R10 is selected from the group consisting of (C1-C4) alkyl optionally substituted by (C3-C7) cycloalkyl and (C3-C7) cycloalkyl; their N-oxides in the pyridine ring, and pharmaceutically acceptable salts thereof.
priorityDate 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466591130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467548773

Total number of triples: 43.